Teva Pharmaceutical Industries
TEVA
NZ$27.65
Share price
-0.18%
Change (1 day)
-2.53%
Change (1 year)
Categories
Revenue for Teva Pharmaceutical Industries (TEVA)
Revenue in 2025 (TTM): NZ$28.01 Billion
According to Teva Pharmaceutical Industries's latest financial reports the company's current revenue (TTM 
) is NZ$27.82 Billion. In 2024 the company made a revenue of NZ$29.33 Billion an increase over the revenue in the year 2023 that were of NZ$25.05 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Teva Pharmaceutical Industries from 1996 to 2025
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2025 (TTM) | NZ$28.01 B | -4.5% |
| 2024 | NZ$29.33 B | 17.07% |
| 2023 | NZ$25.05 B | 6.6% |
| 2022 | NZ$23.50 B | 1.12% |
| 2021 | NZ$23.24 B | 0.7% |
| 2020 | NZ$23.08 B | -5.24% |
| 2019 | NZ$24.36 B | -13.32% |
| 2018 | NZ$28.10 B | -11.07% |
| 2017 | NZ$31.60 B | -0.05% |
| 2016 | NZ$31.62 B | 10.12% |
| 2015 | NZ$28.71 B | 10.98% |
| 2014 | NZ$25.87 B | 4.66% |
| 2013 | NZ$24.72 B | 0.09% |
| 2012 | NZ$24.69 B | 5.26% |
| 2011 | NZ$23.46 B | 12.29% |
| 2010 | NZ$20.89 B | 9.2% |
| 2009 | NZ$19.13 B | 0.18% |
| 2008 | NZ$19.10 B | 55.52% |
| 2007 | NZ$12.28 B | 2.91% |
| 2006 | NZ$11.93 B | 55.38% |
| 2005 | NZ$7.68 B | 14.22% |
| 2004 | NZ$6.72 B | 33.43% |
| 2003 | NZ$5.04 B | 4.73% |
| 2002 | NZ$4.81 B | -3.8% |
| 2001 | NZ$5.00 B | 26.69% |
| 2000 | NZ$3.94 B | 60.91% |
| 1999 | NZ$2.45 B | 15.89% |
| 1998 | NZ$2.11 B | 10.02% |
| 1997 | NZ$1.92 B | 42.57% |
| 1996 | NZ$1.35 B |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Novartis NVS | NZ$89.12 B | 220.33% | 🇨🇭 Switzerland |
 Sanofi SNY | NZ$79.36 B | 185.27% | 🇫🇷 France |
 GlaxoSmithKline GSK | NZ$67.96 B | 144.28% | 🇬🇧 UK |
 Pfizer PFE | NZ$104.59 B | 275.94% | 🇺🇸 USA |
 Merck MRK | NZ$107.03 B | 284.72% | 🇺🇸 USA |
 Dr. Reddy's Laboratories RDY | NZ$6.44 B | -76.85% | 🇮🇳 India |
 AstraZeneca AZN | NZ$92.06 B | 230.92% | 🇬🇧 UK |